HOME >> MEDICINE >> NEWS
Study shows use of budesonide reduced the risk of asthma related events by 40% in children

San Antonio, Tex., - March 19, 2005 New data indicated that earlier intervention with once-daily budesonide, an inhaled corticosteroid delivered by dry powder inhaler to children with mild persistent asthma, significantly reduced the long-term risk and frequency of severe asthma-related events as well as the need for other inhaled medication.

The findings, presented today at the 61st annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI), are from two analyses of the Inhaled Steroid as Regular Therapy in Early Asthma (START) study, a three-year trial involving nearly 2,000 children aged 5 to 10 years with mild persistent asthma. The START study was funded by AstraZeneca.

"Many children with asthma make repeated trips to the emergency room or are hospitalized because of worsening symptoms," said Dr. Albert Sheffer, Clinical Professor of Medicine at Harvard Medical School, Director Emeritus at the Allergy Clinic, Brigham and Women's Hospital in Boston and an investigator in the safety and tolerability portion of the study. "The findings of these two analyses showed that budesonide had a viable long-term treatment effect."

In the first analysis, 1,974 children were randomized to receive either once-daily budesonide or placebo in addition to usual asthma care. The earlier use of budesonide reduced the risk of exacerbation, or severe asthma related events by 40 percent compared to usual asthma care. In addition, children in the budesonide group required fewer interventions with other inhaled corticosteroids (12.3 percent versus 22.7 percent for placebo), and had improved lung function.

The second analysis tracked the adverse side effects reported by 1,981 children taking either budesonide plus usual care or placebo over three years. Overall, the incidence of side effects was comparable between the two groups, with fewer asthma exacerbations and adverse events reported in the budesonide group throughout
'"/>

Contact: Heather Law
heather.law@astrazeneca.com
302-886-1652
Burson-Marsteller
21-Mar-2005


Page: 1 2 3

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
10. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women
11. Study of obese diabetics explains why low-carb diets produce fast results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/15/2019)... ... 2019 , ... Intalere, the healthcare industry leader in delivering ... its Illuminated Path Podcast Series, with the Executive Outlook episode, featuring interviews with ... host Evan Danis, Intalere’s Senior Director of Corporate Communications, shares insight and interviews ...
(Date:5/15/2019)... ... May 15, 2019 , ... SourceLink, an industry-leading omnichannel ... Insurance Strategy. , Stubblefield comes to SourceLink with 10+ years serving in ... corporate marketing and business development. Most recently, he spent several years overseeing ...
(Date:5/14/2019)... ... May 15, 2019 , ... GROW: an awareness journal ... to bloom, facilitating readers to write their way into deeper awareness, cycle through ... creates a mindful space that fosters awareness and transformation. , Christie Havey ...
(Date:5/14/2019)... ... May 14, 2019 , ... The Atlanta Falcons, ... football teams in the U.S. who rely on HydroWorx aquatic therapy pools to ... solutions to accelerate healing,” said Timothy McCarthy, Chief Executive Officer for HydroWorx. ...
(Date:5/14/2019)... ... May 14, 2019 , ... ... in the following majors: Health Science, Exercise Science, Psychology, and Business. These changes ... deans, and Provost, in order to ensure that each program best suits students’ ...
Breaking Medicine News(10 mins):
(Date:5/16/2019)... and FORT WORTH, Texas (PRWEB) , ... May 16, 2019 , ... ... raised $21.7 Million in a Series B financing round. The Series B is ... Partners, participating. , Actuate will use the proceeds of the financing to expand the ...
(Date:5/16/2019)... FRANCISCO (PRWEB) , ... May 16, 2019 , ... ... patient engagement, today announced it has launched Mobile Patient Intake. This new solution ... complete the intake process at their own convenience, on their device of choice, ...
(Date:5/16/2019)... ... May 16, 2019 , ... Though Nefertiti’s Secret—a book by nationally ... via Amazon since April 2019, the author is officially celebrating its publication with a ... invite-only from 5 to 6:30 p.m., then opens to the public at 7 p.m. ...
Breaking Medicine Technology:
Cached News: